Interaction of herpes viruses with HIV: Can antiherpes drugs prolong survival among AIDS patients?

Reviews in Medical Virology

Volumn 6, Issue 3, 1996, Pages 163-172

  Stein, D S ^a   Graham, N M H ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; VALACICLOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; HERPES; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EID: 0029822184     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199609)6:3<163::AID-RMV173>3.0.CO;2-L     Document Type: Review

References (65)

1. Chang, Y., Cesarman, E., Pessin, M. S. et al. (1994). Identification of a herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 226, 1865-1869.
2. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. and Knowles, D. M. (1995). Kaposi's sarcoma associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186-1191.
3. Dupin, N., Gorin, I., Deleuze, J. et al. (1995). Herpes-like DNA sequences, AIDS-related tumors, and Castleman's Disease [letter]. N. Engl. J. Med. 333, 798.
4. Whitby, D., Howard, M. R., Tenant-Flowers, M. et al. (1995). Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346, 799-802.
5. Moore, P. S., Chang, Y. (1995). Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N. Engl. J. Med. 332, 1181-1185.
6. Bigoni, B., Dolcetti, R., de Lellis, L. et al. (1996). Human herpes virus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J. Infect. Dis. 173, 542-549.
7. Laurence, J. (1990). Molecular interactions among herpesviruses and human immunodeficiency viruses. J. Infect. Dis. 162, 338-346.
8. Golden, M. P., Kim, S., Hammer, S. M. et al. (1992). Activation of human immunodeficiency virus by herpes simplex virus. J. Infect. Dis. 166, 494-499.
9. Griffiths, P. D. (1992). Review: Studies to define viral cofactors for human immunodeficiency virus. Infect. Agents Dis. 1, 237-244.
10. von Laer, D., Serr, A., Meyer-Konig, U., Kirste, G., Hufert, F. T. and Haller, O. (1995). Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J. Infect. Dis. 172, 365-370.
11. Pantaleo, G., Graziosi, C. and Fauci. A. S. (1993). The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328, 327-335.
12. Emanuel, D., Cunningham, I., Jules-Elysee, K. et al. (1988). Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann. Intern. Med. 109, 777-782.
13. Reed, E. C., Bowden, R. A., Dandliker, P. S., Lilleby, K. E. and Meyers, J. D. (1988). Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann. Intern. Med. 109, 783-788.
14. Bonetti, A., Weber, R., Vogt, M. W., Wunderli, W., Siegenthaler, W. and Luthy,. R. (1989). Coinfection with human immunodeficiency virus type 1 (HIV-1) and cytomegalovirus in two intravenous drug users. Ann. Intern. Med. 111, 293-296.
15. Berger, D. S., Bucher, G., Reiter, W. M. and Gomatos, P. (1995). Acute retroviral syndrome with CMV coinfection. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract LM100). San Francisco: American Society for Microbiology.
16. Heng, M. C. Y., Heng, S. Y. and Allen, S. G. (1994). Co-infection and synergy of human immunodeficiency virus type 1 and herpes simplex virus-1. Lancet 343, 255-258.
17. Mole, L., Ripich, S., Margolis, D. and Holodniy, M. (1995). Plasma HIV RNA levels are increased during active herpes simplex virus infection. Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections (Abstract 239). Washington DC: Infectious Disease Society of America.
18. Schacker, T., Shaughnessy, M., Barnum, G. and Corey, L. (1995). Reactivation of HSV2 in HIV infected persons is associated with increased levels of plasma HIV RNA. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract 1235). San Francisco: American Society for Microbiology.
19. Koutsky, L. A., Stevens, C. E., Holmes, K. K. et al. (1992). Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N. Engl. J. Med. 326, 1533-1539.
20. Benedetti, J., Corey, L. and Ashley, R. (1994). Recurrence rate in genital herpes after symptomatic first episode infection. Ann. Intern. Med. 121, 847-854.
21. Cone, R. W., Hobson, A. C., Brown, Z. et al. (1994). Frequent detection of genital herpes simplex DNA by polymerase chain reaction among pregnant women. JAMA 272, 792-796.
22. Augenbraun, M., Feldman, J., Chirgwin, K. et al. (1995). Increased genital shedding of Herpes simplex virus type 2 in HIV-seropositive women. Ann. Intern. Med. 123, 845-847.
23. Wald, A., Zeh, J., Selke, S., Ashley, R. L. and Corey, L. (1995). Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 333, 770-775.
24. Detels, R., Leach, C. T., Hennessey, K. et al. (1994). Persistent cytomegalovirus infection of semen increase risk of AIDS. J. Infect. Dis. 169, 766-768.
25. Leach, C. T., Detels, R., Hennessey, K. et al. (1994). A longitudinal study, of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: Molecular epidemiology and association with disease progression. J. Infect. Dis. 170, 293-298.
26. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group (1995). Antiviral effects of foscarnet and ganciclovir therapy on HIV p24 antigen in patients with AIDS and cytomegalovirus retinitis. J. Infect. Dis. 172, 613-621.
27. Stein, D. S., Korvick, J. A. and Vermund, S. H. (1992). CD4 lymphocyte cell enumeration for prediction of clinical course of HIV disease: A review. J. Infect. Dis. 165, 352-363.
28. DeGruttola, V., Beckett, L. A., Coombs, R. W. et al. (1994). Serum p24 antigen level as an intermediate endpoint in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. J. Infect. Dis. 169, 713-721.
29. Dorsky, D. I. and Crumpacker, C. S. (1987). Drugs five years later: Acyclovir. Ann. Intern. Med. 107, 859-874.
30. Whitley, R. J. and Gnann, J. W. (1992). Acyclovir: a decade later. N. Engl. J. Med. 327, 782-789.
31. Tyring, S., Barbarash, R. A., Nahlik, J. E. et al. (1995). Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. Ann. Intern. Med. 123, 89-96.
32. Faulds, D. and Heel, R. C. (1990). Ganciclovir: A review of its antiviral activity, pharmacokinetic properties, and therapeutic efficacy in cytomegalovirus infections. Drugs 39, 597-638.
33. Mitsuya, H. and Broder, S. (1987). Strategies for antiviral therapy in AIDS. Nature 325, 773-778.
34. Mitsuya, H., Matsukura, M. and Broder, S. (1987). Rapid in vitro systems for assessing activity of agents against HTLVflAV. In AIDS.-Modern Concepts and Therapeutic Challenges,ed. by S. Broder, pp. 303-333. Marcel Dekker, New York.
35. Smith, M. S. and Pagano, J. S. (1991). Inhibition of human immunodeficiency virus type 1 replication by guanosine analogues and lack of synergistic antiviral effect of acyclovir with 3′-azido- 3′deoxythymidine. Antivir. Chem. Chemother. 2, 29-34.
36. Tartaglione, T. A., Collier, A. C., Ophiem, K., Gianola, F. G., Benedetti, J. and Corey, L. (1991). Pharmacokinetic evaluations of low and high dose zidovudine plus high dose acyclovir in patients with symptomatic human immunodeficiency virus infection. Antimicrobial. Agents Chemother. 35, 2225-2231.
37. Collier, A. C., Bozzette, S., Coombs, R. W. et al. (1990). A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N. Engl. J. Med. 323, 1015-1021.
38. Cooper, D. A., Pederson, C., Aiuti, F. et al. (1991). The efficacy and safety of zidovudine with or with-out acyclovir in the treatment of patients with AIDS-related complex. AIDS 5, 933-943.
39. Pederson, C., Cooper, D. A., Brun-Vezinet, B. et al. (1992). The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. AIDS 6, 821-825.
40. Cooper, D. A., Pehrson, O., Pederson, C. et al. (1993). The efficacy and safety of zidovudine alone or as cotherapy with acyclovir in the treatment of patients with AIDS and AIDS-related complex: a double blind, randomized trial. AIDS 7, 197-207.
41. Cooper, D. A., Gazzard, B. G., Stevens, J., Bell, A. R. and a European Australian Collaborative Group (1994). The effect of acyclovir cotherapy on survival in individuals with advanced HIV disease. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract 163). Orlando FL: American Society for Microbiology.
42. Youle, M. S., Gazzard, B. G., Johnson, M. A. et al. (1994). Effects of high dose oral acyclovir on herpes-virus disease and survival in patients with advanced HIV disease: a double-blind, placebo controlled trial. AIDS 8, 641-649.
43. Lavelle, J., Lang, W., Lefkowitz, L. et al. (1992). A randomized trial comparing zidovudine alone and in combination with acyclovir for treatment of early symptomatic HIV infection. Abstracts of the VIII International Conference on AIDS (Abstract PoB 3585). Amsterdam: International AIDS Society.
44. Collier, A. C, Schoenfeld, D. A., Bourland, D. et al. (1995). Prospective comparative study of acyclovir and zidovudine versus zidovudine alone in patients with AIDS. Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections (Abstract 383). Orlando FL: Infectious Disease Society of America.
45. Feinberg, J., Cooper, D., and the International Steering Committee for the ACTG 204/Wellcome 123-014 International Study Team (1995). Phase III study of valaciclovir for cytomegalovirus prophylaxis in patients with advanced HIV disease. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract 1214). San Francisco: American Society for Microbiology.
46. Spector, S. A., McKinley, G., Drew, W. L., Stempien, M. J., for the Syntex Ganciclovir Study Group (1995). A randomized double blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV infected persons. Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections (Abstract 2). Washington DC: Infectious Disease Society of America.
47. Brosgrat, C. L., Craig, C., Hillman, D., Louis, T. A. and Alston, B. (1995). A randomized placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of CMV retinal and gastrointestinal mucosal disease in HIV infected individuals with severe immunosuppression. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract LB-10). San Francisco: American Society for Microbiology.
48. Drew, W. L., Miner, R. C., Busch, D. F. et al. (1991). Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J. Infect. Dis. 163, 716-719.
49. Drew, W. L., Miner, R. C., Crager, M. and Stempien, M. J. (1995). Does resistance to ganciclovir develop in patients receiving prophylactic drug? Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract H135). San Francisco: American Society for Microbiology.
50. Drew, W. L., Ives, P., Lalezari, J. et al. (1995). Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N. Engl. J. Med. 333, 615-620.
51. Fife, K. H., Crumpacker, C. S., Mertz, G. J., Hill, E. L., Boone, G. S., and the Acyclovir Study Group (1994). Recurrence and resistance patterns of herpes simplex virus following cessation of ≥6 years of chronic suppression with acyclovir. J. Infect. Dis. 169, 1338-1341.
52. Stein, D. S., Graham, N. M. H., Park, L. P. et al. (1994). The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival in the Multicenter AIDS Cohort Study. Ann. Intern. Med. 121, 100-108.
53. Kaslow, R. A., Ostrow, D. G., Detels, R., Phair, J. P., Polk, B. F. and Rinaldo, C. R. (1987). The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol 126, 310-318.
54. Apolonio, E. G., Hoover, D. R., He, Y. et al. (1995). Prognostic factors in human immunodeficiency virus positive patients with a CD4 lymphocyte count <50/μl. J. Infect. Dis. 171, 829-836.
55. Gallant, J. E., Moore, R. D., Richman, D. D. et al. (1995). Lack of association between acyclovir use and survival in patients with advanced HIV disease treated with zidovudine. J. Infect. Dis. 172, 346-352.
56. Stein, D. S., Graham, N. M. H., Park, L. P., Hoover, D. R. and Saah, A. J. (1996). Acyclovir in human immunodeficiency virus patients. J. Infect. Dis. 173, 504-505 (Letter).
57. Graham, N. M. H., Zeger, S. L., Park, L. P. et al. (1991). Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. Lancet 338, 265-269.
58. Hoover, D. R, Saah, A. J., Bacellar, H. et al. (1993). Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N. Engl. J. Med. 329, 1922-1926.
59. Longini, I. M., Clark, W. S. and Karon, J. M. (1993). Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population based cohort. Am. J. Epidemiol. 137, 1229-1240.
60. Muñoz, A., Schrager, L. K., Bacellar, H. et al. (1993). Trends in the incidence of outcomes defining acquired immune deficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am. J. Epidemiol. 137, 423-438.
61. Farizo, K. M., Buehler, J. W., Chamberland, M. E. et al. (1992). Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 267, 1798-1805.
62. Rogers, M. A., Morens, D. M., Stewart, J. A. et al. (1983). National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2, laboratory results. Ann. Intern. Med. 99, 151-158.
63. Mann, S. L., Meyers, J. D., Holmes, K. L. and Corey, L. (1984). Prevalence and incidence of herpesvirus infections among homosexually active men. J. Infect. Dis. 149, 1026-1027.
64. Quinn, T. C., Piot, P., McCormick, J. B. et al. (1987). Serologic and immunologic studies in patients with AIDS in North America and Africa. JAMA 287, 2617-2621.
65. Siegal, D., Golden, E., Washington, E. et al. (1992). Prevalence and correlates of herpes simplex infections: The population based AIDS in Multiethnic Neighborhoods Study. JAMA 268, 1702-1708.